Across TCGA pan-cancer cohorts, CT45A10 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated CT45A10 data layer compared with 1 for mutation status.
The strongest signal is observed in colon adenocarcinoma (COAD), where higher CT45A10 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CT45A10 expression acts as an unfavorable survival marker, although some lineages such as OV and LUAD show a favorable association.
COAD, KIRC, and OV are the cancer types where CT45A10 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.